APIs & Intermediates Peptides & Amino Acids Metalorganics & Catalysts Fine Chemicals Chromatography Resins
-
Product Name CAS No. Application Azacitidine 320-67-2 API Azacytosine 931-86-2 Azacitidine Tetraacetyl-D-ribose 13035-61-5 Azacitidine Bendamustine / Bendamustine HCl 97832-05-8 / 3543-75-7 API Bortezomid 179324-69-7 API (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate 179324-87-9 Bortezomib N-(2-Pyrazinylcarbonyl)-L-phenylalanine 114457-94-2 Bortezomib Carfilzomib 868540-17-4 API (1-Isobutyl-3-methyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester 247068-81-1 Carfilzomib Benzyl ((S)-2-((tert-butoxycarbonyl)aMino)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate 868540-15-2 Carfilzomib Morpholin-4-yl-acetic acid 3235-69-6 Carfilzomib (alphaS)-alpha-[(4-Morpholinylacetyl)aMino]benzenebutanoyl-L-leucyl-L-phenylalanine 868540-16-3 Carfilzomib ((1S)-3-Methyl-1-(((2R)-2-Methyl-2-oxiranyl)carbonyl)butyl)carbamic acid 1,1-dimethylethyl ester 247068-82-2 Carfilzomib 2,3-Dimethylacetophenone 2142-71-4 Dexmedetomidine HCl (4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid 196404-55-4 Docetaxel 7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III 95603-44-4 Docetaxel Fulvestrant 129453-61-8 API (7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate (N-3) 875573-66-3 Fulvestrant (9-Bromo-nonyloxy)-tert-butyl-dimethyl-silane 149051-24-1 Fulvestrant Dehydronandrolon 2590-41-2 Fulvestrant 4,4,5,5,5-Pentafluoro-1-pentanethiol 148757-88-4 Fulvestrant 4,4,5,5,5-Pentafluoro-1-pentanol 148043-73-6 Fulvestrant S-(4,4,5,5,5-pentafluoropentyl)isothiourea methanesulfonate 1107606-68-7 Fulvestrant Ganciclovir 82410-32-0 API 1,3-Diacetoxy-2-(acetoxymethoxy)propane 86357-13-3 Ganciclovir 4,7-Dichloroquinoline 86-98-6 Hydroxychloroquine 2-[(4-Aminopentyl)(ethyl)amino]ethanol 69559-11-1 Hydroxychloroquine S-mandelic acid 17199-29-0 Hydroxychloroquine 1-Chloro-2-deoxy-3,5-di-O-toluoyl-L-ribofuranose 141846-57-3 Idoxuridine Palonosetron HCl 135729-62-3 API Pemetrexed Disodium (2.5H2O/ 7H2O) 357166-30-4 / 357166-29-1 API 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid 137281-39-1 Pemetrexed Disodium L-Glutamic acid diethyl ester HCl 1118-89-4 Pemetrexed Disodium Gimeracil 103766-25-2 API Oteracil —— API Allantoin 97-59-6 Oteracil Tegafur 17902-23-7 API 5-Fluorouracil 51-21-8 Tegafur Axitinib 319460-85-0 API Crizotinib 877399-52-5 API Dabrafenib 1195765-45-7 API Dasatinib 302962-49-8 API 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302964-24-5 Dasatinib 1-(2-Hydroxyethyl)-piperazine 103-76-4 Dasatinib Ibrutinib 936563-96-1 API Lenvatinib 417716-92-8 API Ponatinib 943319-70-8 API 3-Ethynylimidazo[1,2-b]pyridazine 943320-61-4 Ponatinib 3-Bromoimidazo[1,2-b]pyridazine 18087-73-5 Ponatinib 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline 694499-26-8 Ponatinib Methyl 3-iodo-4-methylbenzoate 90347-66-3 Ponatinib Ruxolitinib 941678-49-5 API 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl-7H-pyrrolo[2,3-d]pyrimidine 941685-27-4 Ruxolitinib 3-Cyclopentyl-acrylonitrile 591769-05-0 Ruxolitinib Sorafenib 284461-73-0 API 4-Chloro-N-methyl pyridine-2-carboxamide 220000-87-3 Sorafenib 4-Chloro-3-(trifluoromethyl)phenyl isocyanate 327-78-6 Sorafenib Trametinib 871700-17-3 API
Disclaimer:
Users are responsible for all patent related issue for our offered products.
The therapeutic/end use shown against each product is indicative only.
Patented Products are available for R&D use.
Information given herein is offered in good faith as accurate, but without guarantee. Conditions of use and suitability of the product for particular uses are beyond our control. All risks of use of the product are therefore assumed by the user.